Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

430 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Urinary tract symptoms that should be improved to enhance post-operative urinary quality of life in patients treated with low-dose-rate brachytherapy for prostate cancer: An importance-performance analysis.
Sakurai T, Takamatsu S, Shibata S, Minamikawa R, Yamazaki M, Okubo A, Nagaoka R, Makino T, Naito R, Yaegashi H, Mizokami A, Kobayashi S. Sakurai T, et al. Among authors: takamatsu s. J Contemp Brachytherapy. 2024 Feb;16(1):12-20. doi: 10.5114/jcb.2024.135646. Epub 2024 Feb 23. J Contemp Brachytherapy. 2024. PMID: 38584886 Free PMC article.
Incidence and dosimetric predictive factors of late rectal toxicity after low-dose-rate brachytherapy combined with volumetric modulated arc therapy in high-risk prostate cancer at a single institution: Retrospective study.
Sakurai T, Takamatsu S, Shibata S, Taka M, Ishiyama M, Yamazaki M, Kojima H, Mizokami A, Kumano T, Gabata T. Sakurai T, et al. Among authors: takamatsu s. Brachytherapy. 2021 May-Jun;20(3):584-594. doi: 10.1016/j.brachy.2020.12.004. Epub 2021 Jan 21. Brachytherapy. 2021. PMID: 33485811
Factors Affecting Prostate Displacement During Volumetric Modulated Arc Therapy in Prone Position After High-Dose-Rate Brachytherapy for Prostate Cancer.
Sakurai T, Takamatsu S, Shibata S, Minamikawa R, Yamazaki M, Kojima H, Noto K, Makino T, Kawaguchi S, Nohara T, Mizokami A, Gabata T. Sakurai T, et al. Among authors: takamatsu s. Adv Radiat Oncol. 2023 May 29;8(6):101277. doi: 10.1016/j.adro.2023.101277. eCollection 2023 Nov-Dec. Adv Radiat Oncol. 2023. PMID: 38047223 Free PMC article.
Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity.
Sakurai T, Takamatsu S, Shibata S, Iwata K, Taka M, Gabata T, Kumano T, Makino T, Mizokami A. Sakurai T, et al. Among authors: takamatsu s. Jpn J Radiol. 2020 Dec;38(12):1197-1208. doi: 10.1007/s11604-020-01023-2. Epub 2020 Jul 31. Jpn J Radiol. 2020. PMID: 32737768
Correction to: Toxicity and clinical outcomes of single‑fraction high‑dose‑rate brachytherapy combined with external beam radiotherapy for high‑/very high‑risk prostate cancer: A dosimetric analysis of toxicity.
Sakurai T, Takamatsu S, Shibata S, Iwata K, Taka M, Kumano T, Makino T, Mizokami A, Gabata T. Sakurai T, et al. Among authors: takamatsu s. Jpn J Radiol. 2021 Apr;39(4):404. doi: 10.1007/s11604-020-01073-6. Jpn J Radiol. 2021. PMID: 33496912 No abstract available.
The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study.
Makino T, Sakurai T, Takamatsu S, Iwamoto H, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Mizokami A. Makino T, et al. Among authors: takamatsu s. Int J Clin Oncol. 2021 Dec;26(12):2310-2317. doi: 10.1007/s10147-021-02023-6. Epub 2021 Sep 7. Int J Clin Oncol. 2021. PMID: 34494172
430 results